January 17, 2017 1:24 AM ET

Biotechnology

Company Overview of 480 Biomedical, Inc.

Key Executives for 480 Biomedical, Inc.

NameBoard RelationshipsTitleAge
Maria Palasis Ph.D.21 RelationshipsChief Executive Officer, President and Director--
Robert S. Langer Jr., Ph.D., Sc.D.615 RelationshipsCo-Founder and Director67
George M. Whitesides Ph.D.103 RelationshipsCo-Founder and Director77
Robert M. Palladino BA, MBA, CPANo RelationshipsChief Financial Officer61
Ray Knox No RelationshipsVice President of Operations--

480 Biomedical, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Richard W. Mott 35 RelationshipsMicrochips Biotech, Inc.--
Maria Palasis Ph.D. 21 RelationshipsArsenal Medical, Inc.--
George M. Whitesides Ph.D. 103 Relationships480 Biomedical, Inc.77
Robert S. Langer Jr., Ph.D., Sc.D. 615 RelationshipsPureTech Health plc67
Carmichael S. Roberts Jr., Ph.D. 199 RelationshipsMC10, Inc.--
View All Board Members

480 Biomedical, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
369.6K
Bonus
253.9K
Total Short Term Compensation
462.2K
Total Value of Options
34.4M
Compensation as of Fiscal Year
480 Biomedical, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

InMed Pharmaceuticals Inc. Appoints Martin Bott to the Board of Directors
January 13, 2017 8:42 PM ET
Uni-Bio Science Group Limited Announces Executive Changes
January 13, 2017 11:38 AM ET
Bioscience Americas, LLC Appoints Shekhar K. Challa to Its Board of Advisors
January 13, 2017 11:30 AM ET
Nivalis Therapeutics, Inc. Announces Management Changes, with Effect from January 15, 2017
January 12, 2017 9:16 PM ET
Immunomedics, Inc. Announces Board Changes
January 12, 2017 9:06 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact 480 Biomedical, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.